Older People With Type 2 Diabetes–Individualising Management With a Specialised Community Team (OPTIMISE): Perspectives of Participants on Care

2021 ◽  
pp. cd200129
Author(s):  
Rajna Ogrin ◽  
Tracy Aylen ◽  
Lorenna Thurgood ◽  
Sandra L. Neoh ◽  
Ralph Audehm ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Older People ◽  
Community Team

scholarly journals Older People with Type 2 diabetes - Individualising Management wIth a SpecialisEd community team: Safety and feasibility study (OPTIMISES): protocol (Preprint)

2019 ◽  
Author(s):  
Rajna Ogrin ◽  
Sandra Neoh ◽  
Tracy Aylen ◽  
Ralph Audehm ◽  
Leonid Churilov ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Older People ◽  
Diabetes Management ◽  
Home Visits ◽  
Tertiary Hospital ◽  
Community Dwelling ◽  
Current Management ◽  
Diabetes Educator ◽  
Community Team

BACKGROUND The prevalence of diabetes is rising in older people. Clinical guidelines recommend that diabetes management should be individualised, however, there is limited information regarding the current management patterns of diabetes in older people. Few individuals achieve optimal glycaemic levels in the general population which could potentially lead to adverse health outcomes and impact quality of life. OBJECTIVE To trial individualised diabetes management intervention for older people through home visits with a credentialed diabetes educator and telehealth consultations with an endocrinologist located at a tertiary hospital. METHODS This paper describes the design and methodology of a mixed methods feasibility and safety study to identify the current management of people 65 years or older with type 2 diabetes. We will implement and evaluate a personalised approach to management in the community of an Australian metropolitan city. This management approach will utilise flash glucose monitoring and home visits with the support of a community home nursing service credentialed diabetes educator and telehealth consultation with an endocrinologist located at a local tertiary hospital. RESULTS Not reported CONCLUSIONS This study is the first of its kind to explore individualised diabetes management for community dwelling older people, aimed to achieve optimal glycaemic levels. The data drawn from this project may be used to inform policy makers, service providers, clinicians and older adults living with diabetes. CLINICALTRIAL Australian Clinical Trial Registration: ACTRN12617000350325

scholarly journals Older People With Type 2 Diabetes—Individualizing Management With a Specialized (OPTIMISE) Community Team: Protocol for a Safety and Feasibility Mixed Methods Study

10.2196/13986 ◽  
2019 ◽  
Vol 8 (6) ◽  
pp. e13986
Author(s):  
Rajna Ogrin ◽  
Sandra Neoh ◽  
Tracy Aylen ◽  
Ralph Audehm ◽  
Leonid Churilov ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Mixed Methods ◽  
Older People ◽  
Mixed Methods Study ◽  
Community Team

scholarly journals Vitamin Intake and Loss of Muscle Mass in Older People with Type 2 Diabetes: A Prospective Study of the KAMOGAWA-DM Cohort

Nutrients ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 2335
Author(s):  
Fuyuko Takahashi ◽  
Yoshitaka Hashimoto ◽  
Ayumi Kaji ◽  
Ryosuke Sakai ◽  
Yuka Kawate ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin D ◽  
Older People ◽  
Vitamin B12 ◽  
Muscle Mass ◽  
Vitamin B1 ◽  
Vitamin D Intake ◽  
Glucagon Like Peptide 1

The aim of this prospective cohort study was to examine the relationships between the intakes of various vitamins and the loss of muscle mass in older people with type 2 diabetes (T2DM). The change in skeletal muscle mass index (SMI, kg/m2) (kg/m2/year) was defined as follows: (SMI at baseline (kg/m2) − SMI at follow-up (kg/m2))/follow-up period (year). The rate of SMI reduction (%) was calculated as follows (the change in SMI (kg/m2/year)/SMI at baseline (kg/m2)) × 100. The rate of SMI reduction ≥ 1.2% was considered as the loss of muscle mass. Among 197 people with T2DM, 47.2% of them experienced the loss of muscle mass at the 13.7 ± 5.2 month follow-up. Vitamin B1 (0.8 ± 0.3 vs. 0.8 ± 0.3 mg/day, p = 0.031), vitamin B12 (11.2 ± 8.3 vs. 13.4 ± 7.5 μg/day, p = 0.049), and vitamin D (16.5 ± 12.2 vs. 21.6 ± 13.0 μg/day, p = 0.004) intakes in people with the loss of muscle mass were significantly lower than those without. Vitamin D intake was related to the loss of muscle mass after adjusting for sex, age, exercise, alcohol, smoking, body mass index, SMI, glucagon-like peptide-1 agonist, sodium glucose cotransporter-2 inhibitor, insulin, HbA1c, creatinine, energy intake, and protein intake (adjusted odds ratio 0.93, 95% confidence interval: 0.88–0.97, p = 0.003). This study showed that vitamin D intake was related to the loss of muscle mass in older people with T2DM. Vitamin B12 intake tended to be related to the loss of muscle mass, although vitamin A, vitamin B2, vitamin B6, vitamin C, and vitamin E intake were not related.

Enhancing care in older people with type 2 diabetes

2007 ◽  
Vol 24 (2) ◽  
pp. 98-101 ◽  
Author(s):  
Alan J Sinclair
Keyword(s):  
Type 2 Diabetes ◽  
Older People

scholarly journals 5.1 The Role of Blood Pressure, Aortic Stiffness, and Haemodynamics in Brain Health in Older People with Type 2 Diabetes Mellitus

2020 ◽  
Vol 25 (Supplement 1) ◽  
pp. S37
Author(s):  
Christopher Karayiannis ◽  
Chris Moran ◽  
Richard Beare ◽  
James Sharman ◽  
Thanh Phan ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Older People ◽  
Aortic Stiffness ◽  
Brain Health
Sign in / Sign up

Export Citation Format

Share Document